These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26975019)

  • 1. Re: Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer.
    Evangelista L; Pasquale R
    Clin Nucl Med; 2016 Sep; 41(9):746. PubMed ID: 26975019
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: Reply.
    Goineau A; Supiot S
    Clin Nucl Med; 2016 Sep; 41(9):746-7. PubMed ID: 27088390
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.
    Goineau A; Colombié M; Rousseau C; Sadot-Lebouvier S; Supiot S
    Clin Nucl Med; 2015 Aug; 40(8):670-1. PubMed ID: 26018683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
    Sahiner I; Akkas BE; Ucmak Vural G
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):193-5. PubMed ID: 23218515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    World J Urol; 2015 Nov; 33(11):1749-52. PubMed ID: 25824540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.
    Ouyang Q; Duan Z; Lei J; Jiao G
    Tumour Biol; 2016 Mar; 37(3):2999-3007. PubMed ID: 26415734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of primary thymic Hodgkin lymphoma in an elderly patient detected by 18F-FDG PET/CT.
    Treglia G; Lococo F; Petrone G; Stefanelli A; Carnassale G; Calcagni ML; Granone P; Giordano A
    Clin Nucl Med; 2013 May; 38(5):e236-8. PubMed ID: 23377412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
    Picchio M; Messa C; Landoni C; Gianolli L; Sironi S; Brioschi M; Matarrese M; Matei DV; De Cobelli F; Del Maschio A; Rocco F; Rigatti P; Fazio F
    J Urol; 2003 Apr; 169(4):1337-40. PubMed ID: 12629355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental diagnosis of diffuse large B-cell lymphoma by 11C-choline PET/CT in a patient with biochemical recurrence of prostate cancer.
    Garzon JG; Bassa P; Moragas M; Soler M; Riera E
    Clin Nucl Med; 2014 Aug; 39(8):742-3. PubMed ID: 24978327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low diagnostic yield of the 11C-choline PET/CT in the detection of liver metastasis from prostate cancer].
    García JR; Franquet E; Romera N; Moragas M; Jorcano S; Moragas G
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):56-7. PubMed ID: 24125594
    [No Abstract]   [Full Text] [Related]  

  • 12. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
    Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
    García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma.
    Adams HJ; Kwee TC
    J Nucl Med; 2017 Apr; 58(4):684-685. PubMed ID: 28373395
    [No Abstract]   [Full Text] [Related]  

  • 15. [18FDG-PET/CT cost-effectiveness compared to CT at the end of treatment in pediatric Hodgkin's lymphoma patients].
    García-Molina M; Chicaíza-Becerra L; Moreno-Calderon A; Prieto-Martínez V; Sarmiento-Urbina I; Linares-Ballesteros A
    Rev Salud Publica (Bogota); 2014; 16(2):260-9. PubMed ID: 25383499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply: Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma.
    Bhethanabhotla S; Bakhshi S
    J Nucl Med; 2017 Apr; 58(4):685-686. PubMed ID: 27932560
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
    Reesink DJ; Fransen van de Putte EE; Vegt E; De Jong J; van Werkhoven E; Mertens LS; Bex A; van der Poel HG; van Rhijn BW; Horenblas S; Meijer RP
    J Urol; 2016 Apr; 195(4 Pt 1):907-12. PubMed ID: 26598424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer.
    Evangelista L; Cimitan M; Hodolič M; Baseric T; Fettich J; Borsatti E
    Abdom Imaging; 2015 Oct; 40(8):3230-7. PubMed ID: 26428685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.